STAT+: Burning questions left unanswered about the latest Alzheimer’s therapy
News of the first clearly successful clinical trial for a new Alzheimer’s disease treatment in…
Author: STAT
A bionic pancreas aims to take the math out of managing type 1 diabetes
For people living with type 1 diabetes, it pays to be good at math. Keeping…
FDA proposes new rules for which foods can be called ‘healthy’
The Food and Drug Administration wants to update its rules for which foods can be…
Early analysis suggests monkeypox vaccine is reducing risk of infection in U.S.
A very preliminary analysis of data from 32 states appears to suggest that the monkeypox…
An Alzheimer’s therapy scores winning results, but what could it mean for patients?
The news Tuesday night that a clinical trial of an experimental Alzheimer’s therapy had succeeded…
STAT+: A ‘disaster’, or a ‘clear path’ forward?: New FDA guidance on AI in medicine sparks strong reactions
New guidance from the Food and Drug Administration is triggering strong reaction from researchers and…
STAT+: If a new Alzheimer’s drug works, was there any point to the Aduhelm controversy? Yes
The announcement Tuesday night from Eisai and Biogen that their experimental medicine, lecanemab, reduced Alzheimer’s…
.jpg)
Virtual drug screening identifies possible new antidepressants in LSD-like molecules
What’s a hallucinogen without the hallucinations? Perhaps a potent and fast-acting antidepressant, according to a…
STAT+: Pharmalittle: Biogen Alzheimer’s drug slowed cognitive decline in a trial; European pharma warns energy costs may halt some generic production
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Virtual Event: When the Barrier to a Breakthrough Drug Is You Can’t Make It
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Lilly is accused by the federal government of discriminating against older sales reps
In an unusual move, the U.S. Equal Employment Opportunity Commission has filed a lawsuit accusing…
Opinion: Medicare needs to cover the full spectrum of care for substance use disorders
Imagine if Medicare covered treatments for stage 1 or stage 4 cancers, but nothing in…
Where caregiving is a family affair, Alzheimer’s places a heavy burden on children and spouses
HARLINGEN, Texas — Here in the Rio Grande Valley almost everyone knows, or cares for,…
Opinion: Listen: How the Dobbs decision could affect how and where clinical trials are conducted
The Supreme Court’s decision to overturn Roe v. Wade opened the door to allow states…
On the Texas-Mexico border, a bold plan to diversify Alzheimer’s research takes shape
BROWNSVILLE, Texas — Gladys Maestre is on a scouting mission. The Alzheimer’s disease researcher is…
Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
An investigational Alzheimer’s disease treatment from Biogen and Eisai slowed the rate of cognitive decline…
In new guidance, FDA says AI tools to warn of sepsis should be regulated as devices
The U.S. Food and Drug Administration on Tuesday published a list of artificial intelligence tools…
Google’s hospital play, Optum’s data shakeup, & the call for more telehealth oversight
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Top FDA official acknowledges agency’s slow process for reviewing health app updates
The Food and Drug Administration’s approach to reviewing updates to software products is far slower…
New study sees possible link between aluminum in childhood vaccines and risk of asthma, but caveats abound
A new study suggests there may be a link between aluminum used in vaccines that…
Health funding battles, a nutrition policy overhaul, and two CBD developments
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: Democrats concede on passing ‘clean’ FDA funding bill; Biogen whistleblower nets $250 million
Good morning, one and all. Damian here, filling in for Ed Silverman once more. Here…
Opinion: The Inflation Reduction Act will help the U.S. achieve maximum vaccine access and uptake, but access gaps remain
One of the many achievements in the Inflation Reduction Act (IRA), which President Biden signed…
Opinion: Doctors who knowingly spread Covid-19 lies should be held accountable
The California State Legislature has sent a bill to Gov. Gavin Newsom that strengthens discipline…
‘It is sinking us even further’: STI clinics, already stretched thin, strain under weight of monkeypox response
At the Los Angeles LGBT Center’s sexual health clinic, patients are normally seen within 24…
STAT+: Google and Fitbit launch new cloud tools to help hospitals use wearables
Google Cloud and Fitbit are rolling out a new offering they hope will ease some…
STAT+: Democrats concede to clean user fee agreement to fund FDA
WASHINGTON — Democrats have conceded to Republican demands and agreed to fund the Food and…
Medicare Advantage boosterism, providers’ surprise billing savior in Texas, and a health insurance firewall
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Pharmalittle: GSK picks its first female CFO; Pfizer advances Omicron booster for kids
Good morning, everyone. Damian Garde here, filling in for Ed Silverman at the outset of…
Opinion: FDA: Ignore a pharma company’s deceptive racial equity argument for keeping Makena, an ineffective preterm labor drug
In an effort to sway the Food and Drug Administration not to withdraw accelerated approval…
STAT+: Health insurers are painting a misleading picture of Medicare Advantage savings, experts say
The health insurance industry is continuing its campaign to convince the public that Medicare Advantage…
Opinion: Subject, not suspect: The new hazards of conducting clinical research in the Dobbs era
Here’s a scenario anyone who has done clinical research will recognize: A 32-year-old woman participating…
STAT+: Biotech turns to new and strange viruses to overcome gene therapy’s limitations
CAMBRIDGE, Mass. — The fluorescent orange sticker atop the white machine reads “BIOHAZARD,” but it’s a…
STAT+: Some European regulators are starting to take steps to ensure clinical trial results are reported
Regulators in half a dozen European countries are now taking steps to enforce requirements that…
‘Disaster to disaster’: Underinvestment in public health systems obstructs response to Covid, monkeypox, Walensky says
For the record, Rochelle Walensky, director of the Centers for Disease Control and Prevention, would…
STAT+: Zuckerberg, Chan want new Harvard institute to answer questions about the brain and AI
For the first time since gifting Harvard University $500 million to launch a new research institute,…
STAT+: Pharmalittle: U.S. drug net prices fell nearly 8% in the second quarter; FDA panel favors fecal-based therapy for bacterial infections
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Solicitor general recommends Supreme Court shouldn’t review an Amgen patent case
In a setback to Amgen, the U.S. solicitor general recommended that the Supreme Court not…
STAT+: White House pitches drug pricing reforms as a way to extend cancer patients’ lives
WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drug pricing…
Shakeup with Optum’s health data licensing sparks an outcry among scientists
A move by Optum to change longstanding practices for licensing data to academic institutions has…
STAT+: Inflation caused another big drop in net drug prices, analysis finds
Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name…
Opinion: Market share isn’t the only metric for biosimilars’ success
Market share is often held up as the most relevant metric for the success of…
Opinion: Gender-affirming care should be embraced, not met with vitriol and bomb threats
As a pediatrician and a parent of a transgender son, I have become increasingly alarmed…
Surgeons often take a fifth of the lungs to remove a small tumor. There may be a better way.
Claudia Donohue was on the operating table first thing in the morning. It wasn’t where…
.jpg)
New Signify details, out-of-state telehealth use, and Fitbits to study brain exercise
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Listen: Biden’s Covid declaration, twilight of the SPAC, & genome editing 2.0
When is a pandemic “over?” Did biotech over-SPAC? And what can’t be CRISPR’d? We cover…
STAT+: New details on Apple Watch study emphasize Medicaid enrollment
Newly published details about a high-profile Apple Watch study calls it “a priority” to recruit…
NIH launches the next stage of its ‘human genome project’ for the brain
The National Institutes of Health on Thursday announced more than $600 million in fresh funding…
STAT+: Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority
Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning,…
Opinion: Public health agencies: learn from NASA about regaining the public’s trust
The amazing images of the Cartwheel Galaxy captured by the James Webb Space Telescope this…